Literature DB >> 29934752

Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies.

Roger B Dodd1, Trevor Wilkinson2, Darren J Schofield1.   

Abstract

Cell surface membrane proteins comprise a wide array of structurally and functionally diverse proteins involved in a variety of important physiological and homeostatic processes. Complex integral membrane proteins, which are embedded in the lipid bilayer by multiple transmembrane-spanning helices, are represented by families of proteins that are important target classes for drug discovery. Such protein families include G-protein-coupled receptors, ion channels and transporters. Although these targets have typically been the domain of small-molecule drugs, the exquisite specificity of monoclonal antibodies offers a significant opportunity to selectively modulate these target proteins. Nevertheless, the isolation of antibodies with desired pharmacological functions has proved difficult because of technical challenges in preparing membrane protein antigens for antibody drug discovery. In this review, we describe recent progress in defining strategies for the generation of membrane protein antigens. We also describe antibody-isolation strategies that identify antibodies that bind the membrane protein and modulate protein function.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29934752     DOI: 10.1007/s40259-018-0289-y

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  10 in total

1.  Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries.

Authors:  Aric Huang; Wei Jin; Ahmed S Fahad; Brooklyn K Mussman; Grazia Paola Nicchia; Bharat Madan; Matheus Oliveira de Souza; J Daniel Griffin; Jeffrey L Bennett; Antonio Frigeri; Cory J Berkland; Brandon J DeKosky
Journal:  Antibodies (Basel)       Date:  2022-06-05

Review 2.  Improving antibody drug development using bionanotechnology.

Authors:  Emily K Makowski; John S Schardt; Peter M Tessier
Journal:  Curr Opin Biotechnol       Date:  2021-12-07       Impact factor: 10.279

3.  Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.

Authors:  Martin J Scott; Amanda Jowett; Martin Orecchia; Peter Ertl; Larissa Ouro-Gnao; Julia Ticehurst; David Gower; John Yates; Katie Poulton; Carol Harris; Michael J Mullin; Kathrine J Smith; Alan P Lewis; Nick Barton; Michael L Washburn; Ruud de Wildt
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

4.  Structure-guided discovery of a single-domain antibody agonist against human apelin receptor.

Authors:  Yanbin Ma; Yao Ding; Xianqiang Song; Xiaochuan Ma; Xun Li; Ning Zhang; Yunpeng Song; Yaping Sun; Yuqing Shen; Wenge Zhong; Liaoyuan A Hu; Yingli Ma; Mei-Yun Zhang
Journal:  Sci Adv       Date:  2020-01-15       Impact factor: 14.136

Review 5.  Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor.

Authors:  Raf Van Campenhout; Serge Muyldermans; Mathieu Vinken; Nick Devoogdt; Timo W M De Groof
Journal:  Biomolecules       Date:  2021-01-06

6.  A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines.

Authors:  Shengli Song; Miriam Manook; Jean Kwun; Annette M Jackson; Stuart J Knechtle; Garnett Kelsoe
Journal:  Commun Biol       Date:  2021-11-25

7.  Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein.

Authors:  Tyng Hwey Tan; Elizabeth Patton; Carol A Munro; Dora E Corzo-Leon; Andrew J Porter; Soumya Palliyil
Journal:  Viruses       Date:  2021-11-02       Impact factor: 5.048

8.  Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody-Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines.

Authors:  Takahiro Anzai; Shinji Saijou; Hiroki Takashima; Misato Hara; Shingo Hanaoka; Yasuhiro Matsumura; Masahiro Yasunaga
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-06

Review 9.  Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.

Authors:  Man-Seok Ju; Sang Taek Jung
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

10.  Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin.

Authors:  Sara Gómez-Melero; Fé Isabel García-Maceira; Tania García-Maceira; Verónica Luna-Guerrero; Gracia Montero-Peñalvo; Isaac Túnez-Fiñana; Elier Paz-Rojas
Journal:  BMC Biotechnol       Date:  2021-07-05       Impact factor: 2.563

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.